Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Diabetologia
Published in: Diabetologia 4/2010

Open Access 01-04-2010 | Commentary

Sense and nonsense in sensors

Authors: J. Hermanides, J. H. DeVries

Published in: Diabetologia | Issue 4/2010

Login to get access

Abstract

Continuous subcutaneous glucose monitoring (CGM) is a developing technology in the treatment of diabetes mellitus. The first randomised controlled trials on its efficacy have been performed. In several studies, CGM lowered HbA1c in adult patients with suboptimally controlled type 1 diabetes mellitus, when selecting compliant patients who tolerate the device. However, as a preventive tool for hypoglycaemia, CGM has not fulfilled the great expectations. Increasing reimbursement of CGM is expected in the near future, awaiting studies on cost-effectiveness.
Literature
1.
2.
Bolinder J, Ungerstedt U, Arner P (1993) Long-term continuous glucose monitoring with microdialysis in ambulatory insulin-dependent diabetic patients. Lancet 342:1080–1085CrossRefPubMed
3.
Bolinder J, Ungerstedt U, Arner P (1992) Microdialysis measurement of the absolute glucose concentration in subcutaneous adipose tissue allowing glucose monitoring in diabetic patients. Diabetologia 35:1177–1180CrossRefPubMed
4.
American Diabetes Association (2008) Standards of medical care in diabetes—2008. Diabetes Care 31:S12–S54CrossRef
5.
6.
Wentholt IM, Maran A, Masurel N, Heine RJ, Hoekstra JB, DeVries JH (2007) Nocturnal hypoglycaemia in type 1 diabetic patients, assessed with continuous glucose monitoring: frequency, duration and associations. Diabet Med 24:527–532CrossRefPubMed
7.
Hanaire H (2006) Continuous glucose monitoring and external insulin pump: towards a subcutaneous closed loop. Diabetes Metab 32:534–538CrossRefPubMed
8.
Gross TM, Bode BW, Einhorn D et al (2000) Performance evaluation of the MiniMed continuous glucose monitoring system during patient home use. Diabetes Technol Ther 2:49–56CrossRefPubMed
9.
Deiss D, Bolinder J, Riveline JP et al (2006) Improved glycemic control in poorly controlled patients with type 1 diabetes using real-time continuous glucose monitoring. Diabetes Care 29:2730–2732CrossRefPubMed
10.
Hirsch IB, Abelseth J, Bode BW et al (2008) Sensor-augmented insulin pump therapy: results of the first randomized treat-to-target study. Diabetes Technol Ther 10:377–383CrossRefPubMed
11.
The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med 359:1464–1476CrossRef
12.
Raccah D, Sulmont V, Reznik Y et al (2009) Incremental value of continuous glucose monitoring when starting pump therapy in patients with poorly controlled type 1 diabetes: the RealTrend study. Diabetes Care 32:2245–2250CrossRefPubMed
13.
Hermanides J, Nørgaard K, Bruttomesso D et al (2009) Sensor augmented pump therapy substantially lowers HbA1c. Diabetologia 52:S43 (Abstract)
14.
Cryer PE (2004) Diverse causes of hypoglycemia-associated autonomic failure in diabetes. N Engl J Med 350:2272–2279CrossRefPubMed
15.
Wentholt IM, Hoekstra JB, DeVries JH (2007) Continuous glucose monitors: the long-awaited watch dogs? Diabetes Technol Ther 9:399–409CrossRefPubMed
16.
Wentholt IM, Hart AA, Hoekstra JB, DeVries JH (2007) Relationship between interstitial and blood glucose in type 1 diabetes patients: delay and the push-pull phenomenon revisited. Diabetes Technol Ther 9:169–175CrossRefPubMed
17.
18.
Roze S, Valentine WJ, Zakrzewska KE, Palmer AJ (2005) Health-economic comparison of continuous subcutaneous insulin infusion with multiple daily injection for the treatment of type 1 diabetes in the UK. Diabet Med 22:1239–1245CrossRefPubMed
19.
Yoo HJ, An HG, Park SY et al (2008) Use of a real time continuous glucose monitoring system as a motivational device for poorly controlled type 2 diabetes. Diabetes Res Clin Pract 82:73–79CrossRefPubMed
20.
Landon MB, Gabbe SG, Piana R, Mennuti MT, Main EK (1987) Neonatal morbidity in pregnancy complicated by diabetes mellitus: predictive value of maternal glycemic profiles. Am J Obstet Gynecol 156:1089–1095PubMed
21.
Murphy HR, Rayman G, Lewis K et al (2008) Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial. BMJ 337:a1680CrossRefPubMed
22.
Sair MPMF, Etherington PJB, Peter Winlove CD, Evans TWM (2001) Tissue oxygenation and perfusion in patients with systemic sepsis. Crit Care Med 29:1343–1349CrossRefPubMed
Metadata
Title
Sense and nonsense in sensors
Authors
J. Hermanides
J. H. DeVries
Publication date
01-04-2010
Publisher
Springer-Verlag
Published in
Diabetologia / Issue 4/2010
Print ISSN: 0012-186X
Electronic ISSN: 1432-0428
DOI
https://doi.org/10.1007/s00125-009-1649-4

Other articles of this Issue 4/2010

Diabetologia 4/2010 Go to the issue

For Debate

The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation

Article

Dimorphic histopathology of long-standing childhood-onset diabetes

Article

Life-course weight characteristics and the risk of gestational diabetes

Article

Birthweight and the risk of childhood-onset type 1 diabetes: a meta-analysis of observational studies using individual patient data

Article

Enhancement of glucagon secretion in mouse and human pancreatic alpha cells by protein kinase C (PKC) involves intracellular trafficking of PKCα and PKCδ

Letter

Insufficient evaluation of adverse events is not a proof of safety

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits